156 related articles for article (PubMed ID: 37893484)
1. Associations of A20, CYLD, Cezanne and JAK2 Genes and Immunophenotype with Psoriasis Susceptibility.
Giang NH; Lien NTK; Trang DT; Huong PT; Hoang NH; Xuan NT
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893484
[No Abstract] [Full Text] [Related]
2. Prevalence of CYLD mutations in Vietnamese patients with polycythemia vera.
Trang DT; Giang NH; Trang BK; Ngoc NT; Giang NV; Canh NX; Vuong NB; Xuan NT
Adv Clin Exp Med; 2022 Apr; 31(4):369-380. PubMed ID: 35025147
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
Li P; Wang Y; Turner JH
Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
[TBL] [Abstract][Full Text] [Related]
4. Effects of Vinblastine and Vincristine on the function of chronic myeloid leukemic cells through expression of A20 and CYLD.
Hoang NH; Huyen NT; Trang DT; Canh NX; Mao CV; Sopjani M; Vuong NB; Xuan NT
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):47-53. PubMed ID: 37114273
[TBL] [Abstract][Full Text] [Related]
5. TNF phase III signalling in tolerant cells is tightly controlled by A20 and CYLD.
Bikker R; Christmann M; Preuß K; Welz B; Friesenhagen J; Dittrich-Breiholz O; Huber R; Brand K
Cell Signal; 2017 Sep; 37():123-135. PubMed ID: 28629782
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling.
Enesa K; Zakkar M; Chaudhury H; Luong le A; Rawlinson L; Mason JC; Haskard DO; Dean JL; Evans PC
J Biol Chem; 2008 Mar; 283(11):7036-45. PubMed ID: 18178551
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell activation by A20 through STAT signaling in acute lymphoblastic leukemia.
Canh NX; Giang NV; Nghia VX; Sopjani M; Ngan NTT; Hoang NH; Xuan NT
J Recept Signal Transduct Res; 2021 Aug; 41(4):331-338. PubMed ID: 32808859
[TBL] [Abstract][Full Text] [Related]
8. TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.
Urbano PCM; Aguirre-Gamboa R; Ashikov A; van Heeswijk B; Krippner-Heidenreich A; Tijssen H; Li Y; Azevedo VF; Smits LJT; Hoentjen F; Joosten I; Koenen HJPM
J Allergy Clin Immunol; 2018 Aug; 142(2):517-529. PubMed ID: 29248493
[TBL] [Abstract][Full Text] [Related]
9. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
[TBL] [Abstract][Full Text] [Related]
10. Hypomorphic A20 expression confers susceptibility to psoriasis.
Aki A; Nagasaki M; Malynn BA; Ma A; Kagari T
PLoS One; 2017; 12(6):e0180481. PubMed ID: 28658319
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis.
Devos M; Mogilenko DA; Fleury S; Gilbert B; Becquart C; Quemener S; Dehondt H; Tougaard P; Staels B; Bachert C; Vandenabeele P; Van Loo G; Staumont-Salle D; Declercq W; Dombrowicz D
J Invest Dermatol; 2019 Jan; 139(1):135-145. PubMed ID: 30118730
[TBL] [Abstract][Full Text] [Related]
12. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
Zhang LM; Zhou JJ; Luo CL
Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
[TBL] [Abstract][Full Text] [Related]
13. Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation.
Jiang Y; Wang W; Zheng X; Jin H
J Immunol Res; 2020; 2020():5980190. PubMed ID: 32280718
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways.
Tian YS; Zhong D; Liu QQ; Zhao XL; Sun HX; Jin J; Wang HN; Li GZ
J Neurosurg; 2018 Mar; 130(3):977-988. PubMed ID: 29521586
[TBL] [Abstract][Full Text] [Related]
15. A20 and CYLD do not share significant overlapping functions during B cell development and activation.
Chu Y; Soberon V; Glockner L; Beyaert R; Massoumi R; van Loo G; Krappmann D; Schmidt-Supprian M
J Immunol; 2012 Nov; 189(9):4437-43. PubMed ID: 23002441
[TBL] [Abstract][Full Text] [Related]
16. CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
[TBL] [Abstract][Full Text] [Related]
17. Expression of deubiquitinases in human gingiva and cultured human gingival fibroblasts.
Fu YW; Xu HZ
BMC Oral Health; 2021 Jun; 21(1):290. PubMed ID: 34092220
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E δ-tocotrienol inhibits TNF-α-stimulated NF-κB activation by up-regulation of anti-inflammatory A20 via modulation of sphingolipid including elevation of intracellular dihydroceramides.
Yang C; Jiang Q
J Nutr Biochem; 2019 Feb; 64():101-109. PubMed ID: 30471562
[TBL] [Abstract][Full Text] [Related]
19. Cylindromatosis (CYLD), a Deubiquitinase, Attenuates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells.
Imaizumi T; Hayakari R; Watanabe S; Aizawa T; Matsumiya T; Yoshida H; Tsuruga K; Kawaguchi S; Tanaka H
Kidney Blood Press Res; 2017; 42(5):942-950. PubMed ID: 29166644
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal ubiquitin-associated domain of Cezanne is crucial for its function to suppress NF-κB pathway.
Ji Y; Cao L; Zeng L; Zhang Z; Xiao Q; Guan P; Chen S; Chen Y; Wang M; Guo D
J Cell Biochem; 2018 Feb; 119(2):1979-1991. PubMed ID: 28817177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
